pharmaphorum November 25, 2021

Healthcare professional (HCP) engagement experienced significant shifts during the acute phase of the pandemic, as COVID-19 forced a rethink of traditional pharmaceutical sales and marketing practices, including the digitisation of events.

With medical conferences and events long a mainstay for pharma-HCP interactions, the pandemic’s travel restrictions, and lockdowns forced these in-person meet-ups to go virtual.

Now, as face-to-face engagement returns to the agenda, all eyes are on the future shape of pharma events as the world starts to navigate its way out of pandemic conditions.

Some key learnings and best practices have already emerged from those events that were run during the pandemic, and there’s a clear desire on the part of many HCPs to retain some of the changed...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Pharma, Pharma / Biotech, Trends
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension
AstraZeneca plans independent drug supply chains for US and China, CEO says
Digital Platforms Streamline Medication Access and Delivery
Pharma Pulse 3/27/24: Patients Hate ‘Forever’ Drugs—Is Wegovy Different? Low Melatonin Can Increase Risk of Neurological Disorders & more
Brainomix AI shows its worth in AZ pulmonary fibrosis trial

Share This Article